Last Modified: January 23, 2002
Date: September 25-28, 2002
Location: Orange County Convention Center, Orlando, Florida, USA
Symposium Web Page: http://cdmrp.army.mil/bcrp/
Sponsors: US Department of Defense Congressionally Directed Medical Research Program
Objectives: To gain greater insight into breast cancer through the scientific exchange between oncology professionals and all individuals whose lives have been touched by breast cancer in some way.
Who should attend: Scientists, physicians, breast cancer survivors and advocates, policymakers, and the general public
Topics: The meeting is organized around topics and research areas including Signal Transduction, Prevention and Targets for Individualized TherapyCell Biology, Prevention, Detection and Diagnosis, Treatment, Signal Transduction, Vaccines, Imaging, Epidemiology, Behavioral, Chemoprevention, Immunology, Clinical and Experimental Therapeutics, Genetics and Molecular Biology, Pathiobiology, Endocrinology, Complementary and Alternative Medicine, Health Care Delivery, Biobehavioral Sciences
Agenda: Exact agenda TBD. The Era of Hope 2002 meeting marks the 10th anniversary of the Department of Defense (DOD) Breast Cancer Research Program (BCRP), a leader in breast cancer research funding. The meeting provides a forum for researchers in different fields and research areas to gather and share their ideas and identify promising new directions in breast cancer research. The perspectives and participation of breast cancer survivors are uniquely incorporated into the meeting. The Era of Hope meeting provides an unprecedented opportunity to highlight the contributions of DOD BCRP research grantees in pushing the boundaries and advancing discoveries in breast cancer research, and to reflect on promising, innovative avenues of research for the upcoming decade.
Continuing Education: Yes. Details will be available online.
Nov 12, 2010 - Alongside a steep decline in the use of hormone therapy, incidence of invasive breast cancer and ductal carcinoma in situ fell in older women undergoing regular mammography in 2002 to 2006, according to research published online Nov. 8 in the Journal of Clinical Oncology.